Entity > Corporation > US > New York City New York > Avinger

About Avinger

Avinger, Inc. is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD).

Avinger, Inc. is Fighting Against PAD: PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.

PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot and Tigereye™ family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices.

Avinger, Inc. was Founded in 2007: Himanshu Patel founded Avinger in 2007, leading the company in the rapid development of new products that address specific unmet clinical needs in the treatment of peripheral artery disease.

Industry: Health

More information about Avinger

Company Attribute Value
Address StreetAddress: 400 Chesapeake Dr, AddressLocality: Redwood City, AddressRegion: California, PostalCode: 94063, AddressCountry: United States
Founding Date 2007
Name Avinger
Number Of Employees 68
Revenue $9,459,000 USD
Ticker Symbol NASDAQ: AVGR
Url avinger
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google



New York City, US
28 Mar 2024

New York City, US
28 Mar 2024


Page: 1 Desktop | Laptop Devices

Avinger: Home
radically changing the way vascular disease is treated. Learn More. 1; 2; 3; 4; 5.
Avinger ISD - Home
The mission of the Avinger Independent School District is to prepare our students to lead successful lives in an ever changing world.
Avinger Funeral Home: Holly Hill, SC Funeral & Cremation
We are committed to providing solid, dependable service in our facility that can be like a second home to you and your family.
https://www.sidley.com › newsannouncements › 2024/03
Sidley Represented Zylox-Tonbridge in Equity Investment ...
Mar 8, 2024 — Avinger is a commercial-stage medical device company developing and ... The PIPE transaction is part of the strategic partnership concurrently ...
https://finance.yahoo.com › quote › AVGR
Avinger, Inc. (AVGR) Stock Price, News, Quote & History
Avinger, Inc. (NASDAQ:AVGR) Q4 2023 Earnings Call Transcript March 20, 2024 Avinger, Inc. misses on earnings expectations. Reported EPS is $-3.93 EPS, ...
https://www.marketwatch.com › Industries
Avinger stock rockets off a record low after launch of ...
Sep 18, 2023 — Shares of Avinger Inc. skyrocketed 63.5% on heavy volume in morning trading Monday, enough to make them the biggest gainers trading on major ...
https://finance.yahoo.com › quote › press-releases
Avinger, Inc. (AVGR) Latest Press Releases & Corporate ...
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based ...
Related Searches
Related Searches
why did avinger stock crash
avinger atherectomy
avinger address
Knowledge Panel
Knowledge Panel

Avinger (Commercial company)


  • Stock price : AVGR (NASDAQ) $2.94 +0.03 (+1.03%)Mar 27, 4:00 PM EDT - Disclaimer
  • Headquarters : Redwood City, CA
  • Founded : 2007

Related Entities Avinger

Entity Home Kalicube Pro Entity Page
Avinger Entity Home Avinger on Kalicube

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193802